U.S. President Donald Trump has signed an executive order directing federal agencies to loosen regulations on marijuana, a move that could mark one of the most significant changes in U.S. cannabis policy in decades. The order instructs the attorney general to move quickly toward reclassifying marijuana under the Controlled Substances Act, potentially shifting it from Schedule I to Schedule III.
If reclassified, marijuana would be grouped with drugs such as certain painkillers, ketamine, and testosterone, which are considered to have accepted medical uses and lower abuse potential. While marijuana would remain illegal at the federal level, the change could dramatically reshape the cannabis industry by expanding medical research opportunities, improving access to funding, and easing barriers for banks and institutional investors.
Trump defended the decision by emphasizing patient needs, saying many Americans suffering from chronic pain have pushed for greater access to marijuana-based treatments. Although he reiterated that he does not personally use the drug and remains cautious about controlled substances, he acknowledged its growing demand and medical relevance.
The move drew mixed reactions in Washington. Senate Democratic Leader Chuck Schumer welcomed the order, calling it a step toward long-overdue reform. In contrast, dozens of Republican lawmakers urged Trump not to proceed, arguing that reclassification could send the wrong message to children, empower drug cartels, and increase safety risks on U.S. roads.
Industry experts noted that congressional action would still be required to establish stable nationwide cannabis regulations. The Drug Enforcement Administration must now review the recommendation, a process that has historically been slowed by bureaucracy. Even with reclassification, marijuana would still face federal restrictions and criminal penalties.
Cannabis stocks initially rose on the news but later fell as investors realized the order did not include provisions for cannabis banking reform. Limited access to traditional financing remains a major challenge for marijuana companies, contributing to high operating costs and the persistence of black-market activity.
Public opinion continues to favor legalization, with most Americans supporting broader reform. Combined with previous efforts, including reviews initiated under former President Joe Biden, Trump’s order signals a continued shift toward easing long-standing federal marijuana policies while leaving the final outcome uncertain.


New York Moves to Ban Masked Law Enforcement During Immigration Operations
Judge Delays SEC Settlement With Elon Musk Over Twitter Stock Disclosure Case
U.S. Sanctions Former DR Congo President Joseph Kabila Over Rebel Support
Dominican Republic Halts GoldQuest Mining Project Amid Environmental Protests
Panama Defends Port Takeover Amid U.S.-China Tensions and Canal Dispute
U.S.-China Beef Trade Deal Hopes Rise Ahead of Trump-Xi Summit
Trump Invites Top CEOs Including Nvidia, Apple, Boeing to China Summit With Xi Jinping
US Sanctions Target Iran’s Shadow Banking Network and Terror Financing
US Reviews Mexican Consulates Amid Rising Diplomatic Tensions
Israel’s Secret Iraq Base Allegedly Supported Iran Air Campaign, WSJ Reports
US Launches Retaliatory Strikes on Iran Amid Rising Strait of Hormuz Tensions
Rubio Approves $25.8 Billion Weapons Sale to Middle East Allies
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Australia’s Wealthy Donors Shift Support to One Nation Amid Conservative Party Decline
China-Made Fireworks Power U.S. Independence Day Celebrations Amid Trade Truce
Senate Stablecoin Bill Sparks Clash Between Banks and Crypto Industry
Rubio Presses Italy Over Iran Support as Tensions Test U.S.-Italy Alliance 



